perindopril has been researched along with Heart Failure in 141 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (2.84) | 18.7374 |
| 1990's | 42 (29.79) | 18.2507 |
| 2000's | 68 (48.23) | 29.6817 |
| 2010's | 22 (15.60) | 24.3611 |
| 2020's | 5 (3.55) | 2.80 |
| Authors | Studies |
|---|---|
| Adamcová, M; Holečková, M; Jirkovský, E; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Palička, V; Pokorná, Z; Šimůnek, T; Štěrba, M | 1 |
| Briasouli, A; Briasoulis, A; Fujisaki, T; Kuno, T; Takagi, H; Ueyama, H | 1 |
| Belenkov, YN; Danilogorskaya, YA; Ilgisonis, IS; Khabarova, NV; Kozhevnikova, MV; P, EV; Safonova, JI; Shchendrygina, AA; Zektser, VY; Zheleznykh, EA | 1 |
| Aiglova, R; Cernicek, V; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M | 1 |
| Arablincky, NA; Kirichenko, AA; Kochetkov, AI; Ostroumova, OD; Romanovsky, RR; Shatalova, NA | 1 |
| Agrawal, H; Albaghdadi, A; Bramblett, T; Mukherjee, D; Teleb, M | 1 |
| Rickenbacher, P | 1 |
| Chen, W; Kuang, XB; Ouyang, S | 1 |
| Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M | 1 |
| Dinicolantonio, JJ; Lavie, CJ; O'Keefe, JH | 1 |
| Chen, J; Du, Q; Hakonarson, H; Hu, A; Liu, J; Wang, H; Wang, X; Wu, J; Xu, L; Zhang, J; Zhang, L; Zhang, Z | 1 |
| Helal, F; Lane, ME | 1 |
| Belenkov, IuN; Danilogorskaia, IuA; Privalova, EV; Shchendrygina, AA; Zheleznykh, EF | 1 |
| Agmadova, ZM; Kallaeva, AN | 1 |
| Bogachev, RS; Kober, DV; Kraĭtser, AP; Rfeenkova, VS | 1 |
| Liskova, IuV; Salikova, SP; Stadnikov, AA | 1 |
| Cressman, AM; Fernandes, KA; Gomes, T; Juurlink, DN; Macdonald, EM; Mamdani, MM; Paterson, JM | 1 |
| Borovkova, NY; Kuznetsova, TE | 1 |
| Borovkov, NN; Borovkova, NJ; Kovaleva, GV; Kuznecova, TE | 1 |
| Belenkov, YN; Chekneva, IS; Danilogorodskaya, YA; Privalova, EV; Shchendrygina, AA; Tishman, MI; Zheleznykh, EA | 1 |
| Artigou, JY; de Groote, P; Diévart, F; Galinier, M; Habib, G; Hanon, O; Herpin, D; Juillière, Y; Komajda, M; Neuder, Y; Roudaut, R; Trochu, JN | 1 |
| Batyraliev, TA; Fettser, DV; Ishlek, M; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Cui, B; Geng, ZH; Li, LG; Liu, CY; Peng, YH; Yu, SY; Zhao, XH | 1 |
| Anderson, C; Arima, H; Chalmers, J; Liu, L; Macmahon, S; Neal, B; Omae, T; Rodgers, A; Tzourio, C; Woodward, M | 1 |
| Ceconi, C; Ferrari, R; Guardigli, G | 1 |
| Banya, W; Beckett, NS; Bulpitt, CJ; Burch, LA; Fagard, R; Fletcher, AE; Gergova, V; Leonetti, G; Peters, R | 1 |
| Chow, K; Ezekowitz, J; Haykowsky, M; Koshman, S; Mackey, JR; Oudit, G; Pagano, JJ; Paterson, I; Pituskin, E; Thompson, RB | 1 |
| Furukawa, M; Hattori, T; Kato, Y; Miyachi, M; Murase, T; Murohara, T; Nagata, K; Ohtake, M; Takahashi, K; Takatsu, M; Tsuboi, K; Yazawa, H | 1 |
| Beckett, N; Bulpitt, C; Burch, L; Fagard, R; Fletcher, A; Li, M; Narkiewicz, K; Nitsch, D; Peters, R; Poulter, R; Wang, N | 1 |
| Bai, S; Cheng, Z; Liang, J; Xu, D | 1 |
| Bicket, DP | 1 |
| Kimura, S; Kohno, M; Mizushige, K; Murakami, K; Noma, T; Tsuji, T | 1 |
| Fraser, CG; Hutcheon, SD; McMurdo, ME; Struthers, AD; Witham, MD | 1 |
| Jia, GL; Li, HF; Li, Y; Liu, F; Wang, XM | 1 |
| Brusca, G; Checkerdhemian, S; Forcada, P; Masuell, M; Pardo, A; Piñeiro, D | 1 |
| Barrios Alonso, V; Campuzano Ruiz, R; Lombera Romero, F; Peña Pérez, G; Peralta, Y | 1 |
| Barry, M; Cahill, J; Ledwidge, M; Maurer, B; McDonald, K; Ryan, E; Ryder, M; Timmons, L; Travers, B | 1 |
| Fox, KM | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Loh, H; Memon, A | 1 |
| Ledwidge, M; McDonald, K; Ryder, M; Timmons, L; Travers, B | 1 |
| Owen, OG | 1 |
| Abe, Y; Aizawa, Y; Ali, F; Hasegawa, G; Hirabayashi, K; Kodama, M; Ma, M; Nagai, Y; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Shirai, K; Soga, M; Suresh, P; Tachikawa, H; Takahashi, T; Wahed, M; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Liebson, PR | 1 |
| Friesewinkel, O; Furrer, M; Hänggi, G; Rutschmann, A | 1 |
| Chen, CS; Hong, Y; Jin, BQ; Li, Y; Li, YN; Liu, XS; Ouyang, WM; Wang, XM | 1 |
| Chirkov, YY; Holmes, AS; Horowitz, JD; Martelli, JD | 1 |
| Böhm, M | 1 |
| Campbell, DJ; Chalmers, JP; Colman, SA; Jenkins, AJ; Kemp, BE; MacMahon, SW; Neal, BC; Patel, A; Woodward, M | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Chen, WF; Dong, YG; Feng, C; He, JG; Leng, XY; Liao, XX; Liu, J; Ma, H; Ma, L; Mai, WY; Tang, AL; Tao, J; Wang, LC; Zeng, WT | 2 |
| Aarons, L; Parker, E; Resplandy, G; Rowland, M | 1 |
| Abashidze, TB; Gorgoshidze, ML | 1 |
| Campo, G; Ceconi, C; Ferrari, R; Gardini, E; Notarstefano, P; Pasanisi, G | 1 |
| Deng, B; Luo, M; Song, HM; Zhang, J | 1 |
| Finsterer, J; Stöllberger, C | 1 |
| Abashidze, TB; Lortkipanidze, RM | 1 |
| Curran, MP; McCormack, PL; Simpson, D | 1 |
| Ambrosio, G; Chiariello, M; Ferrari, R | 1 |
| Nicolosi, GL | 1 |
| Bernocchi, P; Bettini, A; Ceconi, C; Ferrari, R; Gimbatti, OJ; Golcea, SS; Papa, K | 1 |
| Ciliberti, P; Graziosi, M; Rapezzi, C; Riva, L | 1 |
| Ferrari, R | 1 |
| McMurray, J | 1 |
| Adamus, J; Cleland, JG; Freemantle, N; Polonski, L; Taylor, J; Tendera, M | 1 |
| Doehner, W | 1 |
| Chen, W; He, J; Leng, X; Liao, X; Liu, J; Ma, H; Mai, W; Tao, J; Wang, L; Zhen, W | 1 |
| Kinugawa, S | 1 |
| Cleland, JG; Taylor, J; Tendera, M | 1 |
| Bertrand, ME; Deckers, JW; Ferrari, R; Fox, KM; Remme, WJ; Simoons, ML | 1 |
| Remme, WJ | 2 |
| Fujii, M; Horie, M; Nakae, I; Nishiyama, K; Ohnishi, M; Sakai, H; Tanaka, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Drexler, H; Hornig, B; Jeserich, M; Just, H; Kupfer, M; Lohmann, A; Münzel, T; Olschewski, M; Pape, L | 1 |
| Compagnon, P; Desché, P; Devaux, B; el Fertak, L; Henry, JP; Macé, B; Mulder, P; Richard, V; Scalbert, E; Thuillez, C | 1 |
| Ogilvie, RI; Zborowska-Sluis, D | 1 |
| Matthews, JM; Molenaar, P; Summers, RJ | 1 |
| Blaysat, G; Compagnon, P; Desche, P; Elfertak, L; Henry, JP; Mulder, P; Richard, V; Scalbert, E; Thuillez, C | 1 |
| Sami, MH | 1 |
| Bounhoure, JP; Desche, P; Garnham, SP; Lechat, P | 1 |
| Chassing, A; Flammang, D; Waynberger, M | 1 |
| Antony, I; Desche, P; Lerebours, G; Robert, S; Violet, I; Weber, C | 1 |
| Gorodetskaya, EA; Medvedev, OS | 1 |
| Auzépy, P; Depret, J; Giudicelli, JF; Richard, C; Thuillez, C | 1 |
| Chemla, D; Coirault, C; Desche, P; Lambert, F; Lecarpentier, Y; Pery, N; Scalbert, E; Suard, I | 1 |
| Young, BA | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL; Squire, IB | 2 |
| Arnal, JF; Laboulandine, I; Michel, JB; Philippe, M | 1 |
| Desche, P; Dews, IM; Resplandy, G; Robinson, J; Stephens, JD; Vandenburg, MJ | 1 |
| Devlin, A; Lees, KR; MacFayden, RJ; Reid, JL; Squire, IB | 1 |
| Chemla, D; Coirault, C; Desche, P; Lambert, F; Lecarpentier, Y; Lerebours, G; Scalbert, E | 1 |
| Aalkjaer, C; Cumin, F; Kahr, O; Kelly, MP; Samani, NJ | 1 |
| Bagger, JP | 1 |
| MacFadyen, RJ | 1 |
| Lees, KR; Reid, JL | 1 |
| Cleland, JG | 1 |
| Tan, LB; Wright, DJ | 1 |
| Demidova, IV; Drozdov, VN; Levchuk, NN; Moiseev, VS; Tereshchenko, SN | 1 |
| Demidova, IV; Kobalova, ZhD; Moiseev, VS; Tereshchenko, SN | 1 |
| Gu, XH; Kompa, AR; Summers, RJ | 1 |
| Busuttil, W; Galea, J; Manché, A | 1 |
| Gallois, H; Haïat, R; Hanania, G; Piot, O | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Sami, M | 1 |
| Adamus, J; Cleland, JG; Freemantle, N; Gray, CS; Lye, M; O'Mahony, D; Polonski, L; Taylor, J; Tendera, M | 1 |
| Spinar, J; Vítovec, J | 1 |
| Sanderson, JE | 1 |
| Bogatyreva, NV; Efimova, EG; Egorova, LA; Khalezova, MA; Lutaĭ, AV; Shutemova, EA | 1 |
| Begley, F; Burke, T; Cahill, J; Kelly, J; Ledwidge, M; Maurer, B; McDonald, K; Quigley, P; Ryder, M; Timmons, L; Travers, B | 1 |
| Francis, GS; Gassler, JP | 1 |
| Chemla, D; Coirault, C; Fratacci, MD; Guérot, C; Hagège, A; Lecarpentier, Y | 1 |
| Bellissant, E; Giudicelli, JF | 1 |
| Fomina, IG; Gaĭdamakina, NE; Georgadze, ZO; Matveev, VV; Nagieva, AZ; Sinitsyna, MG | 1 |
| Sonnenblick, EH | 1 |
| Aleksandriia, LG; Kobalava, ZhD; Moiseev, VS; Tereshchenko, SN | 1 |
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Bizet-Nafeh, C; Costentin, A; Cribier, A; Derumeaux, G; Iacob, M; Joannides, R; Thuillez, C | 1 |
| Ditiatkov, AE; Radzevich, AE; Tikhonov, VA | 1 |
| De Rooy, SE; De Vries, OO; Jansen, PA; Raymakers, JA | 1 |
| Domergue, V; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C; Trabold, F | 1 |
| Anthopoulos, L; Apostolou, T; Bonoris, P; Foussas, S; Lefkos, N; Zombolos, S | 1 |
| Fujii, H; Harada, E; Ito, T; Mizuno, Y; Nakamura, S; Nakao, K; Nakayama, M; Ogawa, H; Saito, Y; Sakamoto, T; Shimasaki, Y; Yamamoto, N; Yasue, H; Yoshimura, M | 1 |
| Mangiaracina, G; Perdikis, DA | 1 |
| Demidova, IV; Kobalava, ZhD; Moiseev, VS; Tereshchenko, SN | 1 |
| Goa, KL; Noble, S; Simpson, D | 1 |
| Boissel, JP; Chifflet, R; Girard, P; Leizorovicz, A; Lievre, M; Nony, P | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL | 1 |
| Auzepy, P; Giudicelli, JF; Loueslati, H; Richard, C; Thuillez, C | 1 |
| Genissel, P; Resplandy, G | 1 |
| Chemla, D; Desché, P; Lecarpentier, Y; Scalbert, E | 1 |
| Bounhoure, JP | 1 |
| Giudicelli, JF; Richard, C; Richer, C; Thuillez, C | 1 |
| Michel, JB | 1 |
| Devissaguet, M; Mossiat, C; Ribuot, C; Rochette, L | 1 |
| Bottineau, G; Bounhoure, JP; Garnham, J; Lapeyre, G; Lechat, P | 2 |
| Auzepy, P; Bottineau, G; Giudicelli, JF; Pezzano, M; Richard, C; Thuillez, C | 1 |
| Auzépy, P; Giudicelli, JF; Loueslati, H; Perret, L; Richard, C; Richer, C; Thuillez, C | 1 |
23 review(s) available for perindopril and Heart Failure
| Article | Year |
|---|---|
Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Drug Combinations; Heart Failure; Hospitalization; Humans; Irbesartan; Mineralocorticoid Receptor Antagonists; Mortality; Network Meta-Analysis; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Spironolactone; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan | 2020 |
Heart Failure with Preserved Ejection Fraction: Entresto a Possible Option.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Drug Combinations; Heart; Heart Failure; Humans; Irbesartan; Perindopril; Tetrazoles; Valsartan | 2017 |
[Heart failure with "mid-range" ejection fraction: a new clinical entity?]
Topics: Aged; Aminobutyrates; Benzimidazoles; Biomarkers; Biphenyl Compounds; Comorbidity; Coronary Disease; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Natriuretic Peptides; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Spironolactone; Stroke Volume; Survival Rate; Syndrome; Tetrazoles; Valsartan | 2018 |
Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cardiovascular System; Coronary Disease; Heart Failure; Humans; Hypertension; Myocardial Infarction; Perindopril; Ramipril | 2013 |
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
Treatment of heart failure with preserved systolic function.
Topics: Adrenergic beta-Antagonists; Adult; Aged, 80 and over; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Benzopyrans; Blood Pressure; Cardiotonic Agents; Digoxin; Ethanolamines; Heart Failure; Heart Rate; Humans; Hypertension; Myocardial Ischemia; Nebivolol; Perindopril; Randomized Controlled Trials as Topic; Registries; Renal Artery Obstruction; Systole; Treatment Outcome | 2008 |
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Specific properties and effect of perindopril in controlling the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Perindopril; Renin-Angiotensin System | 2005 |
Perindopril: a review of its use in patients with or at risk of developing coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Coronary Artery Disease; Heart Failure; Humans; Perindopril; Prodrugs; Risk; Treatment Outcome | 2006 |
[Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Ventricular Remodeling | 2005 |
[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2005 |
[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Time Factors | 2005 |
[Diabetic heart disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Heart Failure; Humans; Insulin Resistance; Myocardial Contraction; Myocardial Infarction; Perindopril; Tetrazoles; Ventricular Remodeling | 2007 |
Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Europe; Female; Heart Arrest; Heart Failure; Humans; Male; Myocardial Infarction; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Rate | 2007 |
Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Disease Progression; Enalapril; Heart Failure; Humans; Perindopril; Propanolamines; Treatment Outcome; Ventricular Remodeling | 2007 |
Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Indoles; Perindopril | 1994 |
Regional hemodynamic effects of perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Forearm; Heart Failure; Hemodynamics; Humans; Indoles; Laser-Doppler Flowmetry; Perindopril; Regional Blood Flow; Renal Circulation | 1993 |
Perindopril treatment for congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Perindopril; Severity of Illness Index | 2001 |
Perindopril: in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Failure; Hemodynamics; Humans; Perindopril; Randomized Controlled Trials as Topic | 2002 |
Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Enalapril; Follow-Up Studies; Heart Failure; Humans; Indoles; Meta-Analysis as Topic; Perindopril; Survival Rate | 1992 |
Pharmacokinetics of perindopril in high-risk populations.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Indoles; Kidney Failure, Chronic; Liver Diseases; Perindopril | 1991 |
[Cardiomyopathy in the Syrian hamster. Physiological and therapeutic aspects].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Calcium Metabolism Disorders; Cardiomyopathies; Cricetinae; Heart Failure; Homeostasis; Indoles; Models, Biological; Perindopril | 1991 |
42 trial(s) available for perindopril and Heart Failure
| Article | Year |
|---|---|
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Asian People; Blood Pressure; Cerebrovascular Disorders; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Risk Factors; Stroke; Vascular Diseases; White People | 2010 |
Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Indapamide; Male; Perindopril; Stroke | 2012 |
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzu
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Apoptosis; Bisoprolol; Breast Neoplasms; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Perindopril; Placebos; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Research Design; Trastuzumab; Ventricular Remodeling | 2011 |
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
Topics: Age Factors; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Male; Perindopril; Proportional Hazards Models; Proteinuria; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2013 |
[Effect of different doses of perindopril on myocardial energy expenditure in patients with heart failure following myocardial infarction].
Topics: Aged; Energy Metabolism; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Perindopril; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2012 |
[Utility of perindopril in mild-moderate heart failure in daily clinical practice. METRICA trial].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Perindopril; Severity of Illness Index | 2003 |
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2003 |
Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Decision Making; Digoxin; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Health Care Costs; Heart Failure; Hospitalization; Humans; Ireland; Length of Stay; Male; Middle Aged; Perindopril; Prospective Studies; Time Factors; Ventricular Dysfunction, Left | 2003 |
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cause of Death; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Treatment Outcome | 2003 |
[Severe heart failure: treatment optimisation and monitoring using plasma NT-proBNP levels--an useful tool in clinical practice].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Heart Failure; Humans; Hypertension; Indapamide; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Perindopril; Propanolamines; Reference Values | 2004 |
[Effects of perindopril on plasma soluble TRAIL and receptor soluble DR5 in patients with congestive heart failure].
Topics: Apoptosis; Heart Failure; Humans; Perindopril; Receptors, TNF-Related Apoptosis-Inducing Ligand; Ventricular Remodeling | 2003 |
Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Female; Heart Failure; Heart Ventricles; Humans; Male; Perindopril; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome | 2005 |
[Effect of a combination of teveten and prestarium in patients with chronic heart failure].
Topics: Acrylates; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Imidazoles; Male; Perindopril; Thiophenes | 2005 |
[Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Perindopril | 2005 |
[Effect of prestarium in patients with chronic heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Arrhythmia, Sinus; Chronic Disease; Heart Failure; Humans; Middle Aged; Perindopril; Quality of Life | 2005 |
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diastole; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Treatment Outcome; Ventricular Remodeling | 2006 |
The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Perindopril; Survival Analysis; Treatment Outcome | 2006 |
Prognosis in heart failure with a normal ejection fraction.
Topics: Aged; Antihypertensive Agents; Biomarkers; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Patient Selection; Peptide Fragments; Perindopril; Prognosis; Stroke Volume | 2007 |
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Perindopril; Radionuclide Imaging; Risk Factors; Stroke Volume; Sympathetic Nervous System; Treatment Outcome | 2008 |
Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril | 1993 |
Acceptability of perindopril in mild-to-moderate chronic congestive heart failure. Results of a long-term open study in 320 patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Exercise Test; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome | 1993 |
Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Prodrugs | 1993 |
Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose.
Topics: Acetylcholinesterase; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril | 1993 |
Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Rate; Humans; Indoles; Male; Middle Aged; Perindopril; Renin; Renin-Angiotensin System | 1996 |
[The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Indoles; Male; Middle Aged; Myocardial Contraction; Perindopril; Time Factors | 1997 |
Tolerance to ACE inhibitors after cardiac surgery.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Bypass; Drug Hypersensitivity; Enalapril; Feasibility Studies; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Indoles; Length of Stay; Middle Aged; Myocardial Infarction; Perindopril; Prognosis; Renal Insufficiency | 1999 |
Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Echocardiography; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Indoles; Male; Myocardial Ischemia; Patient Dropouts; Perindopril; Time Factors; Ventricular Dysfunction, Left | 1999 |
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Echocardiography; Electrocardiography; Heart Failure; Humans; Perindopril; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Ventricular Function, Left | 1999 |
First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Dose-Response Relationship, Drug; Enalapril; Female; Heart Failure; Humans; Hypotension; Incidence; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors; Single-Blind Method; Stroke Volume | 2000 |
[Effectiveness of prestarium in the treatment of chronic cor pulmonale].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Echocardiography; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Perindopril; Potassium; Pulmonary Heart Disease; Quality of Life; Time Factors | 2000 |
Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzy
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Patient Care Team; Patient Discharge; Patient Readmission; Perindopril; Recurrence; Risk Factors; Survival Rate | 2001 |
Pharmacokinetic-pharmacodynamic model for perindoprilat regional haemodynamic effects in healthy volunteers and in congestive heart failure patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Cardiovascular Agents; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Vascular Resistance | 2001 |
[Effects of perstarium on the systolic and diastolic functions of the myocardium in patients with chronic cardiac failure].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril | 2001 |
[Hypotension followed the first dose of angiotensin-converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Perindopril | 2001 |
Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Female; Hand; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Perindopril; Radial Artery; Regional Blood Flow; Skin; Stress, Mechanical; Vasodilation; Vasodilator Agents | 2001 |
A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Perindopril; Ventricular Dysfunction, Left | 2001 |
Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hypotension; Male; Perindopril; Risk Factors | 2001 |
Effects of perindopril on aldosterone production in the failing human heart.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Catheterization; Female; Heart Failure; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Statistics as Topic; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Chronic Disease; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Rate; Humans; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Renin | 1991 |
[Perindopril and chronic heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Double-Blind Method; Exercise Test; Heart Failure; Hemodynamics; Humans; Indoles; Perindopril | 1991 |
[Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Indoles; Middle Aged; Multicenter Studies as Topic; Perindopril; Pilot Projects; Random Allocation | 1989 |
Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Heart Failure; Humans; Indoles; Middle Aged; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 1989 |
76 other study(ies) available for perindopril and Heart Failure
| Article | Year |
|---|---|
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Daunorubicin; Heart Diseases; Heart Failure; Male; Perindopril; Rabbits; Troponin T | 2022 |
[Positive Effects of Perindopril on Microvascular Vessels in Patients With Chronic Heart Failure].
Topics: Heart Failure; Humans; Perindopril; Stroke Volume; Vascular Stiffness; Ventricular Function, Left | 2020 |
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Czech Republic; Heart Failure; Humans; Losartan; Neprilysin; Perindopril; Ramipril; Retrospective Studies; Telmisartan; Valsartan | 2022 |
[What do we Mean by "Ideal" Blood Pressure Control?]
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Heart Failure; Humans; Hypertension; Myocardial Infarction; Perindopril | 2021 |
[Effects of perindopril on expression of kidney aquaporin-2 and urine aquaporin-2 excretion in chronic heart failure rats].
Topics: Animals; Aquaporin 2; Disease Models, Animal; Heart Failure; Kidney; Male; Perindopril; Rats; Rats, Sprague-Dawley | 2013 |
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System | 2013 |
Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor.
Topics: Aged; Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Autoantibodies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Molecular Sequence Data; Perindopril; Prospective Studies; Receptor, Angiotensin, Type 1; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2013 |
[Effect of 6-month therapy with perindopril A on structural-functional state of arterial vascular bed in patients with chronic heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hyperemia; Male; Middle Aged; Perindopril; Vasodilation | 2014 |
[Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].
Topics: Aged; Angina, Unstable; Aspirin; Benzopyrans; Cardiovascular Agents; Disease Progression; Drug Therapy, Combination; Echocardiography, Doppler; Ethanolamines; Female; Heart Failure; Humans; Male; Middle Aged; Nebivolol; Outcome Assessment, Health Care; Perindopril; Platelet Aggregation Inhibitors; Prognosis; Severity of Illness Index; Simvastatin; Time Factors; Ventricular Remodeling | 2014 |
[Clinical aspects of vaso-and cardioprotection in patients with primary and recurrent myocardial infarction].
Topics: Cardiotonic Agents; Coronary Angiography; Coronary Vessels; Drug Combinations; Endothelium-Dependent Relaxing Factors; Femoral Artery; Heart Failure; Humans; Indapamide; Male; Middle Aged; Myocardial Infarction; Perindopril; Recurrence; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Color; Vasoconstriction; Ventricular Remodeling | 2014 |
[Extracellular matrix remodeling myocardium of the left ventricle rats with experimental heart failure after perindopril and melatonin administration].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Disease Models, Animal; Extracellular Matrix; Heart Failure; Heart Ventricles; Male; Matrix Metalloproteinase 1; Melatonin; Models, Cardiovascular; Perindopril; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome; Ventricular Remodeling | 2014 |
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Clopidogrel; Databases, Factual; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Lisinopril; Male; Myocardial Infarction; Perindopril; Platelet Aggregation Inhibitors; Ramipril; Recurrence; Ticlopidine; Treatment Outcome | 2015 |
[EFFECTIVENESS OF FIXED COMBINATION OF PERINDOPRILARGININE AND AMLODIPINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION WITH CONCOMITANT CHRONIC CARDIAC INSUFFICIENCY AND SIGNS OF CHRONIC KIDNEY DISEASE].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Monitoring; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Perindopril; Prospective Studies; Renal Insufficiency, Chronic; Russia; Severity of Illness Index; Treatment Outcome | 2015 |
[Therapy of Arterial Hypertension in Patients With Chronic Heart Failure and Signs of Chronic Kidney Disease With Fixed Perindopril/Amlodipine Combination].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Essential Hypertension; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
[Effect of 12-Months Therapy With Perindopril A on Structural-Functional State of the Microcirculatory Vascular Bed in Patients With Chronic Heart Failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Perindopril; Severity of Illness Index; Vasodilation | 2015 |
[Arterial hypertension in persons older than 80 years: the problem can be successfully solved].
Topics: Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Confidence Intervals; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2008 |
[Effect of carvedilol and perindopril on Ca(2+) pump activity and Ca(2+)-release channel density in myocardial sarcoplasmic reticulum in rats with chronic heart failure following myocardial infarction].
Topics: Animals; Calcium; Carbazoles; Carvedilol; Drug Therapy, Combination; Heart Failure; Male; Myocardial Infarction; Perindopril; Propanolamines; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum | 2009 |
Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Models, Animal; Heart Failure; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Neovascularization, Physiologic; Nitric Oxide Synthase; Perindopril; Rats; Rats, Inbred Dahl; Vascular Endothelial Growth Factor A | 2011 |
Perindopril effect on uncoupling protein and energy metabolism in failing rat hearts.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Atrial Natriuretic Factor; Blood Pressure; Echocardiography, Doppler; Energy Metabolism; Heart; Heart Failure; Heart Rate; Ion Channels; Male; Membrane Transport Proteins; Mitochondrial Proteins; Myocardium; Organ Size; Perindopril; Phosphocreatine; Protein Biosynthesis; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uncoupling Protein 2 | 2002 |
Grossly elevated serum angiotensin-converting enzyme activities are still suppressible with ACE inhibitor therapy.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Male; Peptidyl-Dipeptidase A; Perindopril | 2002 |
Effects of perindopril on soluble intercellular adhesion molecule-1 in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Female; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Perindopril | 2002 |
ACE inhibitors in heart failure--switching from enalapril to perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Echocardiography; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Perindopril; Prospective Studies; Radionuclide Imaging; Regression Analysis; Statistics, Nonparametric; Treatment Outcome | 2002 |
Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Azetidines; Benzimidazoles; Benzylamines; Biphenyl Compounds; Coronary Disease; Europe; Heart Failure; Humans; Natriuretic Peptide, Brain; Perindopril; Prodrugs; Randomized Controlled Trials as Topic; Tetrazoles | 2003 |
Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Urea Nitrogen; Creatinine; Drug Administration Schedule; Drug Monitoring; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Kidney Function Tests; Length of Stay; Male; Nurse Clinicians; Nursing Evaluation Research; Perindopril; Potassium; Program Evaluation; Safety; Severity of Illness Index; Treatment Outcome | 2003 |
EUROPA shows role for ACE inhibition in low-risk CHD.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2003 |
Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
Topics: Administration, Oral; Angiotensin I; Animals; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hemodynamics; Hypertension; Infusions, Intravenous; Male; Pericardial Effusion; Perindopril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Pressure | 2003 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cyclic GMP; Female; Heart Failure; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Perindopril; Platelet Aggregation; Platelet Function Tests; Superoxides; Time Factors; Ventricular Dysfunction, Left | 2004 |
[ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study].
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Coronary Disease; Female; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cerebrovascular Disorders; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Perindopril; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Stroke | 2005 |
Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Heart Failure; Heart Ventricles; Male; Myocytes, Cardiac; Perindopril; Rats; Rats, Wistar; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger | 2005 |
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Creatinine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Models, Biological; Perindopril; Renal Insufficiency | 2005 |
[Effects of ACE inhibitor on the calcium transient and calcium handling proteins in ventricular myocytes from rats with heart failure].
Topics: Animals; Calcium; Calmodulin; Heart Failure; Male; Myocytes, Cardiac; Perindopril; Rats; Rats, Wistar | 2005 |
Can perindopril delay the onset of heart failure in duchenne muscular dystrophy?
Topics: Child; Heart Failure; Humans; Muscular Dystrophy, Duchenne; Perindopril; Time Factors | 2005 |
[The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Heart Failure; Humans; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Time Factors; Ventricular Remodeling | 2005 |
Renin angiotensin blockade in heart failure with preserved ejection fraction: The signal gets stronger.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 2006 |
World Congress of Cardiology 2006. Barcelona, Spain, September 2-5, 2006.
Topics: Adrenergic beta-Antagonists; Androgens; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Monitoring, Ambulatory; Perindopril; Spain; Stem Cell Transplantation; Telemedicine; Testosterone | 2007 |
Angiotensin-converting enzyme inhibitor improves force and Ca2 +--frequency relationships in myocytes from rats with heart failure.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Aniline Compounds; Animals; Blotting, Western; Calcium-Binding Proteins; Disease Models, Animal; Fluorescent Dyes; Heart Failure; Heart Ventricles; Male; Microscopy, Confocal; Myocardial Contraction; Myocytes, Cardiac; Perindopril; Random Allocation; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Xanthenes | 2007 |
Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Radial Artery; Vascular Resistance; Vasodilation | 1995 |
Vascular and myocardial protective effects of converting enzyme inhibition in experimental heart failure.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Collagen; Endothelium, Vascular; Heart; Heart Failure; Indoles; Male; Mesenteric Arteries; Myocardium; Perindopril; Rats; Rats, Wistar; Vasodilation; Ventricular Pressure | 1995 |
Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Disease Models, Animal; Dogs; Heart Failure; Hemodynamics; Indoles; Perindopril; Vascular Capacitance | 1995 |
Beta-adrenoceptor subtypes in the atrioventricular conducting system and myocardium of spontaneously hypertensive rats: effects of angiotensin-converting enzyme inhibition by perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Bundle of His; Cardiomegaly; Disease Models, Animal; Female; Heart; Heart Failure; Indoles; Infusion Pumps; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Receptors, Adrenergic, beta; Tissue Distribution | 1994 |
Prevention of endothelial dysfunction in small and large arteries in a model of chronic heart failure. Effect of angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Chronic Disease; Disease Models, Animal; Endothelium, Vascular; Heart Failure; Hemodynamics; Indoles; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Perindopril; Random Allocation; Rats; Rats, Wistar; Vasodilation | 1995 |
Acute and long-term efficacy of perindopril in severe chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Indoles; Male; Middle Aged; Perindopril | 1993 |
Systemic and regional hemodynamic effects of perindopril in experimental heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Failure; Hemodynamics; Indoles; Perindopril; Rats; Rats, Wistar; Regional Blood Flow; Vascular Resistance; Veins | 1993 |
Intrinsic alterations of diaphragm muscle in experimental cardiomyopathy.
Topics: Acetylcholinesterase; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomechanical Phenomena; Cricetinae; Diaphragm; Heart Failure; Indoles; Isometric Contraction; Perindopril | 1993 |
ACE inhibitor first dose effect.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dipeptides; Heart Failure; Humans; Hypotension; Indoles; Lisinopril; Middle Aged; Perindopril | 1993 |
Effect of perindopril in rat cardiac volume overload.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Heart Failure; Indoles; Male; Myocardium; Organ Size; Perindopril; Rats; Rats, Inbred SHR; Rats, Wistar | 1993 |
Digoxin pharmacokinetics and perindopril in heart failure patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Female; Heart Failure; Humans; Indoles; Male; Perindopril; Time Factors | 1993 |
Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomechanical Phenomena; Cardiomyopathies; Cricetinae; Diaphragm; Heart Failure; Indoles; Isometric Contraction; Mesocricetus; Peptidyl-Dipeptidase A; Perindopril | 1997 |
Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blotting, Northern; Heart Failure; Indoles; Kidney; Liver; Lung; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Wistar; Renin | 1997 |
Adverse event with first-dose perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebral Infarction; Heart Failure; Hemianopsia; Humans; Hypotension; Indoles; Male; Middle Aged; Perindopril | 1997 |
Adverse event with first-dose perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hypotension; Indoles; Perindopril; Research Design | 1997 |
Adverse event with first-dose perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Monitoring; Heart Failure; Humans; Hypotension; Indoles; Perindopril; Time Factors | 1997 |
Adverse event with first-dose perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Heart Failure; Humans; Hypotension; Indoles; Perindopril | 1997 |
Adverse event with first-dose perindopril in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cerebral Infarction; Heart Failure; Hemianopsia; Humans; Hypotension; Indoles; Perindopril | 1997 |
[Change of circadian pattern of arterial pressure in patients with congestive heart failure treated with perindopril, an inhibitor of angiotensin-converting enzyme (ACE)].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Indoles; Male; Middle Aged; Myocardial Infarction; Perindopril; Stroke Volume; Treatment Outcome | 1997 |
Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Body Weight; Down-Regulation; Female; Heart Failure; Indoles; Iodocyanopindolol; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Pindolol; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta | 1998 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Exercise Therapy; Heart Failure; Humans; Hypertension; Hypotension; Indoles; Perindopril | 1999 |
Re: The PEP-CHF study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Hong Kong; Humans; Perindopril; Ventricular Function, Left | 2000 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Perindopril; Prospective Studies; Respiratory Muscles; Stroke Volume | 2001 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Emotions; Heart Failure; Hemodynamics; Humans; Perindopril; Pulmonary Heart Disease; Quality of Life; Ramipril; Socioeconomic Factors; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2001 |
Blood pressure reduction after the first dose of captopril and perindopril.
Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hypotension; Male; Perindopril; Risk Factors | 2001 |
Coronary dilatation reserve in experimental hypertension and chronic heart failure: effects of blockade of the renin-angiotensin system.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Coronary Vessels; Gene Deletion; Heart; Heart Failure; Hemodynamics; Hypertension; Irbesartan; Kallikrein-Kinin System; Kallikreins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Bradykinin B2; Receptors, Bradykinin; Renin-Angiotensin System; Tetrazoles; Vasodilation | 2001 |
Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypotension; Lisinopril; Perindopril | 2001 |
Should perindopril be used to treat patients with heart failure?
Topics: Angiotensin-Converting Enzyme Inhibitors; Family Practice; Heart Failure; Humans; Isoquinolines; Perindopril; Tetrahydroisoquinolines | 2002 |
[Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Coronary Circulation; Female; Genotype; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic | 2002 |
Systemic and regional hemodynamic effects of perindopril in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Heart Failure; Hemodynamics; Humans; Indoles; Male; Perindopril | 1990 |
Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output; Heart Failure; Hemodynamics; Humans; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance; Vasodilation | 1991 |
Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen; Disease Models, Animal; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hypertension; Indoles; Male; Myocardial Contraction; Myocardial Infarction; Myosins; Organ Size; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; RNA, Messenger | 1990 |
Beneficial effect of perindopril, an angiotensin-converting enzyme inhibitor, on left ventricular performance and noradrenaline myocardial content during cardiac failure development in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output; Cardiomegaly; Coronary Circulation; Heart Failure; Heart Rate; In Vitro Techniques; Indoles; Male; Myocardium; Norepinephrine; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Ventricular Function, Left | 1990 |
Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Body Surface Area; Cardiac Output; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Oxygen; Oxygen Consumption; Perindopril; Pulmonary Gas Exchange | 1989 |
Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brachial Artery; Forearm; Heart Failure; Heart Rate; Humans; Indoles; Peptidyl-Dipeptidase A; Perindopril; Regional Blood Flow; Renin; Vascular Resistance | 1988 |